| 34D Stock | | | EUR 102.40 0.65 0.64% |
CEO
Mr. Carlo Rosa has acted as Chief Executive Officer, Executive Director, General Manager of Diasorin S.p.A. since 2006. He graduated in Chemistry from Universita degli Studi di Torino. From 1990 to 1998, he was responsible for various research projects at Biomedica SpA and INCSTAR Inc. In 1998, he served as Director of Marketing and Sales at DiaSorin. In 2000, he was appointed General Manager of DiaSorin Group. In 2002, he was appointed Chief Executive Officer at DiaSorin GmbH. Currently, he serves as Sole Director at Sarago Srl and as Director of TOP Srl and Diasorin Inc. since 2006.
| Age | 57 |
| Tenure | 18 years |
| Phone | 39 01 614871 |
| Web | https://diasoringroup.com |
DiaSorin SpA Management Efficiency
The company has return on total asset
(ROA) of
0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.
DiaSorin SpA has accumulated 1.23
B in total debt with debt to equity ratio
(D/E) of 3.0, implying the company greatly
relies on financing operations through barrowing. DiaSorin SpA has a current ratio of 2.94, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DiaSorin SpA until it has trouble settling it off, either with new capital or with free cash flow. So, DiaSorin SpA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DiaSorin SpA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DiaSorin to invest in growth at high rates of return. When we think about DiaSorin SpA's use of debt, we should always consider it together with cash and equity.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN S operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1928 people. DiaSorin SpA (34D) is traded on Frankfurt Exchange in Germany and employs 3,313 people.
Management Performance
DiaSorin SpA Leadership Team
Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fabrizio Bonelli, Chief Officer | |
| Carlo Rosa, CEO, Executive Director, General Manager | |
| Piergiorgio Pedron, Senior Corporate VP and CFO | |
| Ulisse Spada, Mang Department | |
| Angelo Rago, Pres Corp | |
| Stefano Ronchi, Senior Corporate Vice President - Human Resources | |
| Ugo Gay, Sr Operations | |
| Chen Even, Senior Corporate Vice President - Commercial Operations and Executive Director | |
| Riccardo Fava, External Relations Director, Head of Investor Relations and Media | |
DiaSorin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Stock
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.